ATE483983T1 - Verfahren zur diagnose von chronischem stress und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Info

Publication number
ATE483983T1
ATE483983T1 AT05734530T AT05734530T ATE483983T1 AT E483983 T1 ATE483983 T1 AT E483983T1 AT 05734530 T AT05734530 T AT 05734530T AT 05734530 T AT05734530 T AT 05734530T AT E483983 T1 ATE483983 T1 AT E483983T1
Authority
AT
Austria
Prior art keywords
chronic stress
related diseases
diagnosing chronic
diagnosing
stress
Prior art date
Application number
AT05734530T
Other languages
English (en)
Inventor
Marie Asberg
Ake Nygren
Rolf Ekman
Original Assignee
Randox Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Lab Ltd filed Critical Randox Lab Ltd
Application granted granted Critical
Publication of ATE483983T1 publication Critical patent/ATE483983T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/485—Epidermal growth factor [EGF] (urogastrone)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Control Of Eletrric Generators (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT05734530T 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen ATE483983T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409153.4A GB0409153D0 (en) 2004-04-23 2004-04-23 Method of diagnosis
PCT/GB2005/001417 WO2005103723A2 (en) 2004-04-23 2005-04-14 Method for the diagnosis of chronic stress and related disorders

Publications (1)

Publication Number Publication Date
ATE483983T1 true ATE483983T1 (de) 2010-10-15

Family

ID=32344337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05734530T ATE483983T1 (de) 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Country Status (6)

Country Link
US (1) US7507584B2 (de)
EP (1) EP1743179B1 (de)
AT (1) ATE483983T1 (de)
DE (1) DE602005023973D1 (de)
GB (1) GB0409153D0 (de)
WO (1) WO2005103723A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2325657C1 (ru) * 2007-03-30 2008-05-27 Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) Способ прогноза неблагоприятного затяжного течения ревматоидного увеита
US20110245092A1 (en) * 2008-03-04 2011-10-06 John Bilello Diagnosing and monitoring depression disorders based on multiple serum biomarker panels
US8747311B2 (en) * 2009-11-19 2014-06-10 Make3Wishes, Llc Method and apparatus for evaluating the effects of internal and external stress influences

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879902A (en) * 1997-06-16 1999-03-09 Neuro-Biotech Inc. Diagnostic methods and kits for the evaluation of the sympathetic nervous system function
US6653135B1 (en) * 2000-09-13 2003-11-25 University Of Maryland Dynamic protein signature assay
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
US7605128B2 (en) 2002-02-14 2009-10-20 Buck Institute For Age Research Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia

Also Published As

Publication number Publication date
US20080153172A1 (en) 2008-06-26
WO2005103723A3 (en) 2006-04-27
EP1743179B1 (de) 2010-10-06
US7507584B2 (en) 2009-03-24
GB0409153D0 (en) 2004-05-26
WO2005103723A2 (en) 2005-11-03
EP1743179A2 (de) 2007-01-17
DE602005023973D1 (de) 2010-11-18

Similar Documents

Publication Publication Date Title
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
ATE438853T1 (de) Diagnostische testvorrichtung
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
DE60315373D1 (de) Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten
ATE508202T1 (de) Verfahren zur diagnose von brustkrebs
WO2005114164A3 (en) Voltammetric systems for assaying biological analytes
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
DE602006012033D1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a-komplexe in einer blutprobe
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
NZ599054A (en) Diagnosis of collagen IX destruction
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
DE602006017058D1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE483982T1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties